- Home
- BDRX vs RELI Comparison
BDRX vs RELI Comparison
Compare BDRX & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- RELI
- Stock Information
- Founded
- BDRX 2000
- RELI 2013
- Country
- BDRX United Kingdom
- RELI United States
- Employees
- BDRX N/A
- RELI N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- RELI Specialty Insurers
- Sector
- BDRX Health Care
- RELI Finance
- Exchange
- BDRX Nasdaq
- RELI Nasdaq
- Market Cap
- BDRX 3.6M
- RELI 3.5M
- IPO Year
- BDRX N/A
- RELI N/A
- Fundamental
- Price
- BDRX $1.15
- RELI $1.47
- Analyst Decision
- BDRX
- RELI
- Analyst Count
- BDRX 0
- RELI 0
- Target Price
- BDRX N/A
- RELI N/A
- AVG Volume (30 Days)
- BDRX 3.6M
- RELI 41.1K
- Earning Date
- BDRX 04-11-2025
- RELI 07-24-2025
- Dividend Yield
- BDRX N/A
- RELI N/A
- EPS Growth
- BDRX N/A
- RELI N/A
- EPS
- BDRX N/A
- RELI N/A
- Revenue
- BDRX N/A
- RELI $14,208,143.00
- Revenue This Year
- BDRX N/A
- RELI N/A
- Revenue Next Year
- BDRX N/A
- RELI N/A
- P/E Ratio
- BDRX N/A
- RELI N/A
- Revenue Growth
- BDRX N/A
- RELI 2.40
- 52 Week Low
- BDRX $1.01
- RELI $0.97
- 52 Week High
- BDRX $41.50
- RELI $18.53
- Technical
- Relative Strength Index (RSI)
- BDRX 39.66
- RELI 68.56
- Support Level
- BDRX $1.01
- RELI $1.29
- Resistance Level
- BDRX $1.26
- RELI $1.56
- Average True Range (ATR)
- BDRX 0.12
- RELI 0.09
- MACD
- BDRX 0.01
- RELI 0.03
- Stochastic Oscillator
- BDRX 15.22
- RELI 80.00
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.